Anti-HIV-1 nanotherapeutics: promises and challenges for the future

Mahajan, Supriya D.; Aalinkeel, Ravikumar; Law, Wing-Cheung; Reynolds, Jessica L.; Nair, Bindukumar B.; Sykes, Donald E.; Yong, Ken-Tye; Roy, Indrajit; Prasad, Paras N.; Schwartz, Stanley A.
December 2012
International Journal of Nanomedicine;2012 Part 2, Vol. 7, p5301
Academic Journal
No abstract available.


Related Articles

  • Emerging Drugs for the Treatment of Human Immunodeficiency Virus. Bhopale, Girish M. // Recent Patents on Anti-Infective Drug Discovery;Apr2012, Vol. 7 Issue 1, p45 

    Rapid emergence of drug resistant Human Immunodeficiency virus (HIV) variants and severe side effects of anti-HIV drugs limit the efficacy of existing anti-HIV therapies. Efforts are being made to develop newer anti-HIV agents. Few newer anti-HIV agents reached the different clinical phases...

  • Active-Targeted Nanotherapy Strategies for Prostate Cancer. Katsogiannou, M.; Peng, L.; Catapano, C. V.; Rocchi, P. // Current Cancer Drug Targets;Oct2011, Vol. 11 Issue 8, p954 

    Castration-resistant prostate cancer remains incurable and a major cause of mortality worldwide. The absence of effective therapeutic approaches for advanced prostate cancer has led to an intensive search for novel treatments. Emerging nanomedical approaches have shown promising results, in...

  • Current Drug Design of Anti-HIV Agents Through the Inhibition of C-C Chemokine Receptor Type 5. Speck-Planche, Alejandro; Dias Soeiro Cordeiro, Maria Nat├ília // Current Computer-Aided Drug Design;Dec2011, Vol. 7 Issue 4, p238 

    Human immunodeficiency virus (HIV) is the responsible causal agent of acquired immunodeficiency syndrome (AIDS),a condition in humans in which the immune system begins to fail, allowing the entry of opportunistic infections. HIV infection in humans is considered pandemic by the World Health...

  • Small is Beautiful: What Can Nanotechnology Do for Personalized Medicine? Marchant, G. E. // Current Pharmacogenomics & Personalized Medicine;2009, Vol. 7 Issue 4, p231 

    Nanotechnology and personalized medicine are two of the most rapidly emerging areas of biomedical research, as well as two of the most promising technologies for improving health care and health outcomes. They are also rapidly converging in numerous current and future clinical applications....

  • Drug Targeting Systems for Cancer Therapy: Nanotechnological Approach. Aydin, R. Seda Tigli // Mini Reviews in Medicinal Chemistry;Nov2014, Vol. 14 Issue 13, p1048 

    Progress in cancer treatment remains challenging because of the great nature of tumor cells to be drug resistant. However, advances in the field of nanotechnology have enabled the delivery of drugs for cancer treatment by passively and actively targeting to tumor cells with nanoparticles....

  • Potential Drug Targets on the HIV-1 Envelope Glycoproteins, gp120 and gp41. Li Huang; Zhang, Linda; Chin Ho Chen // Current Pharmaceutical Design;Jul2003, Vol. 9 Issue 18, p1453 

    HIV-1 entry is an attractive target for anti-HIV-1 therapy. However, there are no entry inhibitors approved for the clinical treatment of HIV-1 infection. This is likely to be changed in the near future since promising HIV-1 entry inhibitors, such as T20 and some chemokine receptor antagonists,...

  • Novel Dual Small-Molecule HIV inhibitors: Scaffolds and Discovery Strategies. Song, Anran; Haiqing Yu; Changyuan Wang; Xingqi Zhu; Kexin Liu; Xiaodong Ma // Current Pharmaceutical Design;Feb2015, Vol. 21 Issue 7, p950 

    Searching for safe and effective treatments for HIV infection is still a great challenge worldwide in spite of the 27 marketed anti-HIV drugs and the powerful highly active antiretroviral therapy (HAART). As a promising prospect for generation of new HIV therapy drugs, multiple ligands (MDLs)...

  • Algal Lectins for Potential Prevention of HIV Transmission. Yuqin Li; Xuewu Zhang; Gu Chen; Dong Wei; Feng Chen // Current Medicinal Chemistry;2008, Vol. 15 Issue 11, p1096 

    A number of lectins that bind high-mannose carbohydrates on the surface of the envelopes of virus has been found to have antiviral activity. In particular, some algal lectins such as Cyanovirin-N, Microcystis viridis lectin, Scytovirin, Griffithsin and Oscillatoria agardhii agglutinin, exhibit...

  • Therapeutic Genes for Anti-HIV/AIDS Gene Therapy. Bovolenta, Chiara; Porcellini, Simona; Alberici, Luca // Current Pharmaceutical Biotechnology;Jun2013, Vol. 14 Issue 5, p488 

    The multiple therapeutic approaches developed so far to cope HIV-1 infection, such as anti-retroviral drugs, germicides and several attempts of therapeutic vaccination have provided significant amelioration in terms of life-quality and survival rate of AIDS patients. Nevertheless, no approach...

  • Novel phyto-anti-HIV drugs: a cause for optimism. Jassim, Sabah A. A. // Biologist;Oct2005, Vol. 52 Issue 5, p268 

    Focuses on the future of phyto-anti-HIV drugs development. Sources of lead compounds in the search for new drugs and medicines used for the treatment of HIV/AIDS; Evaluation of the antiviral activity of different chemical constituents extracted from medicinal plants; Potential of many plants and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics